Generics maker Hikma is looking to ease the U.S. shortage of hydromorphone with increased production as the FDA gave its OK to Terumo BCT to shore up short supplies of anticoagulant solution.
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, announced today that it has expanded its collaboration with Mallinckrodt